Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U ...
) has been revised to $7.65 / share. This is an increase of 12.50% from the prior estimate of $6.80 dated February 21, 2026. The price target is an average of many targets provided by analysts. The ...
Microbot Medical Inc. MBOT recently signed a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System. The company has received the ...
Microbot Medical (ISIN US59503A2042) was last at USD 1.12 on Nasdaq on October 7, 2026, up 4.67 percent, while its average analyst target stood at USD 6.33 after a revision. The contrast puts ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results